on AFYREN (EPA:ALAFY)
AFYREN Reveals 2026 Half-Year Financial Performance
AFYREN, a greentech enterprise specializing in biobased ingredients, disclosed its 2026 mid-year financial outcomes, demonstrating an industrial evolution and advancements in production capacities. With the acquisition of its NEOXY plant, AFYREN now fully controls and optimizes its production processes, enhancing its industrial prowess.
The company's strategic focus on differentiation and certifications aligns with current industry trends, securing market outlets with potential price increases. Financially, AFYREN maintains a cash reserve of €17.3 million and secured €12.5 million in venture debt from BNP Paribas.
Looking ahead, AFYREN aims to double NEOXY's revenue in the second half of 2026 compared to the first. The investment agenda centered around achieving break-even and preparing for future plant models solidifies their market stance.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all AFYREN news